FDA warns two web­sites sell­ing No­vo, Lil­ly block­buster weight loss drugs

The FDA on Tues­day re­leased two warn­ing let­ters for web­sites sell­ing unau­tho­rized ver­sions of the block­buster weight loss and di­a­betes drugs con­tain­ing semaglu­tide, like Ozem­pic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.